Literature DB >> 20205595

Primary bronchial epithelial cell culture from explanted cystic fibrosis lungs.

Malcolm Brodlie1, Michael C McKean, Gail E Johnson, John D Perry, Audrey Nicholson, Bernard Verdon, Michael A Gray, John H Dark, Jeffrey P Pearson, Andrew J Fisher, Paul A Corris, James Lordan, Christopher Ward.   

Abstract

Lung disease is responsible for more than 95% of morbidity and mortality in cystic fibrosis. The exact pathogenesis of cystic fibrosis lung disease remains poorly understood. Experimental models are therefore vital for use in research. Animal models and immortalized cell lines both have inherent limitations. Explanted lungs removed from people with cystic fibrosis at the time of transplantation represent a potentially valuable but technically and logistically challenging source of primary cystic fibrosis bronchial epithelial cells. In this study, pieces of segmental bronchus from explanted lungs were treated with patient-specific antimicrobials prior to isolation of bronchial epithelial cells. Cultured cells were characterized by their morphology under light microscopy, cytokeratin and hematoxylin-eosin staining, and electrophysiological profile. Primary bronchial epithelial cells were successfully cultured from 15 of 22 patients attempted. The cells exhibited typical epithelial morphology, staining for cytokeratin, lack of responsiveness to forskolin treatment, and remained viable after storage in liquid nitrogen. Seven unsuccessful cultures failed due to early infection with bacteria known to colonize the airways pretransplant. The results show that primary bronchial epithelial cell culture is possible from explanted cystic fibrosis lungs. This provides an important cellular model to elucidate the pathogenic mechanisms in cystic fibrosis lung disease and to investigate potential therapeutic targets.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20205595     DOI: 10.3109/01902140903165265

Source DB:  PubMed          Journal:  Exp Lung Res        ISSN: 0190-2148            Impact factor:   2.459


  10 in total

Review 1.  Barriers to inhaled gene therapy of obstructive lung diseases: A review.

Authors:  Namho Kim; Gregg A Duncan; Justin Hanes; Jung Soo Suk
Journal:  J Control Release       Date:  2016-05-16       Impact factor: 9.776

2.  Elevated paracellular glucose flux across cystic fibrosis airway epithelial monolayers is an important factor for Pseudomonas aeruginosa growth.

Authors:  James P Garnett; Michael A Gray; Robert Tarran; Malcolm Brodlie; Christopher Ward; Emma H Baker; Deborah L Baines
Journal:  PLoS One       Date:  2013-10-04       Impact factor: 3.240

3.  Hyperglycaemia and Pseudomonas aeruginosa acidify cystic fibrosis airway surface liquid by elevating epithelial monocarboxylate transporter 2 dependent lactate-H+ secretion.

Authors:  James Peter Garnett; Kameljit K Kalsi; Mirko Sobotta; Jade Bearham; Georgina Carr; Jason Powell; Malcolm Brodlie; Christopher Ward; Robert Tarran; Deborah L Baines
Journal:  Sci Rep       Date:  2016-11-29       Impact factor: 4.379

4.  β1-Integrin Accumulates in Cystic Fibrosis Luminal Airway Epithelial Membranes and Decreases Sphingosine, Promoting Bacterial Infections.

Authors:  Heike Grassmé; Brian Henry; Regan Ziobro; Katrin Anne Becker; Joachim Riethmüller; Aaron Gardner; Aaron P Seitz; Joerg Steinmann; Stephan Lang; Christopher Ward; Edward H Schuchman; Charles C Caldwell; Markus Kamler; Michael J Edwards; Malcolm Brodlie; Erich Gulbins
Journal:  Cell Host Microbe       Date:  2017-05-25       Impact factor: 21.023

5.  Targeting the Bacterial Cytoskeleton of the Burkholderia cepacia Complex for Antimicrobial Development: A Cautionary Tale.

Authors:  Sonya C Carnell; John D Perry; Lee Borthwick; Daniela Vollmer; Jacob Biboy; Marcella Facchini; Alessandra Bragonzi; Alba Silipo; Annette C Vergunst; Waldemar Vollmer; Anjam C M Khan; Anthony De Soyza
Journal:  Int J Mol Sci       Date:  2018-05-30       Impact factor: 5.923

6.  Establishment of an immortalized human subglottic epithelial cell line.

Authors:  Jason Powell; Bernard Verdon; Janet A Wilson; A John Simpson; Jeffery Pearson; Chris Ward
Journal:  Laryngoscope       Date:  2019-01-08       Impact factor: 2.970

7.  Recombinant Acid Ceramidase Reduces Inflammation and Infection in Cystic Fibrosis.

Authors:  Aaron I Gardner; Iram J Haq; A John Simpson; Katrin A Becker; John Gallagher; Vinciane Saint-Criq; Bernard Verdon; Emily Mavin; Alexandra Trigg; Michael A Gray; Albert Koulman; Melissa J McDonnell; Andrew J Fisher; Elizabeth L Kramer; John P Clancy; Christopher Ward; Edward H Schuchman; Erich Gulbins; Malcolm Brodlie
Journal:  Am J Respir Crit Care Med       Date:  2020-10-15       Impact factor: 21.405

Review 8.  From Submerged Cultures to 3D Cell Culture Models: Evolution of Nasal Epithelial Cells in Asthma Research and Virus Infection.

Authors:  Malik Aydin; Ella A Naumova; Aliyah Bellm; Ann-Kathrin Behrendt; Federica Giachero; Nora Bahlmann; Wenli Zhang; Stefan Wirth; Friedrich Paulsen; Wolfgang H Arnold; Anja Ehrhardt
Journal:  Viruses       Date:  2021-02-28       Impact factor: 5.048

Review 9.  Targeted therapies to improve CFTR function in cystic fibrosis.

Authors:  Malcolm Brodlie; Iram J Haq; Katie Roberts; J Stuart Elborn
Journal:  Genome Med       Date:  2015-09-24       Impact factor: 11.117

10.  A novel fluorescent sensor protein for detecting changes in airway surface liquid glucose concentration.

Authors:  Nordine Helassa; James P Garnett; Matthew Farrant; Faaizah Khan; John C Pickup; Klaus M Hahn; Christopher J MacNevin; Robert Tarran; Deborah L Baines
Journal:  Biochem J       Date:  2014-12-01       Impact factor: 3.857

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.